Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Median LCS (internal name) / eyonis LCS (trade name) (1.0)

K-Number: K251474 · 2026-02-06

ApplicantMedian Technologies
Decision Date2026-02-06
Product CodeQDQ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

Median LCS (internal name) / eyonis LCS (trade name) (1.0) is the device name listed in this FDA 510(k) record. The listed applicant is Median Technologies. It received FDA 510(k) clearance on 2026-02-06 under 510(k) number K251474. The device is classified under product code QDQ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Median LCS (internal name) / eyonis LCS (trade name) (1.0)?

Median LCS (internal name) / eyonis LCS (trade name) (1.0) is a medical device that received FDA 510(k) clearance on 2026-02-06. The listed applicant is Median Technologies. The 510(k) number is K251474.

When did Median LCS (internal name) / eyonis LCS (trade name) (1.0) receive FDA 510(k) clearance?

Median LCS (internal name) / eyonis LCS (trade name) (1.0) received FDA 510(k) clearance on 2026-02-06, under 510(k) number K251474.

Who is the listed applicant for Median LCS (internal name) / eyonis LCS (trade name) (1.0)?

The FDA 510(k) record lists Median Technologies as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Median LCS (internal name) / eyonis LCS (trade name) (1.0)?

The FDA product code for Median LCS (internal name) / eyonis LCS (trade name) (1.0) is QDQ.

Related Devices (Code: QDQ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K260898Transpara (2.1.0)Screenpoint Medical B.V.K260086CadAI-B DxBeamWorks, Inc.K260303See-Mode Augmented Reporting Tool, Breast (SMART-B)See-Mode Technologies Pty, Ltd.K260714MammoScreen® (5)TherapixelK253825Saige-DxDeepHealth, Inc.K253682DeepHealth ProstateAIQuantib B.V.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑